2-[6-[6-[(5-methyl-1,3-thiazol-2-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]quinazolin-4-amine
C23H23N7S — CID 155725193
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-[6-[(5-methyl-1,3-thiazol-2-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]quinazolin-4-amine
2-[6-[6-[(5-methyl-1,3-thiazol-2-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]quinazolin-4-amine (PubChem CID 155725193) has the molecular formula C23H23N7S and a molecular weight of 429.55 g/mol. Its IUPAC name is 2-[6-[6-[(5-methyl-1,3-thiazol-2-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]quinazolin-4-amine.
Molecular Properties
| Compound Name | 2-[6-[6-[(5-methyl-1,3-thiazol-2-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]quinazolin-4-amine |
|---|---|
| PubChem CID | 155725193 |
| Molecular Formula | C23H23N7S |
| Molecular Weight | 429.55 g/mol |
| Exact Mass | 429.17 |
| IUPAC Name | 2-[6-[6-[(5-methyl-1,3-thiazol-2-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]quinazolin-4-amine |
| SMILES | Cc1cnc(CN2C3CC2CN(c2ccc(-c4nc(N)c5ccccc5n4)cn2)C3)s1 |
| InChI | InChI=1S/C23H23N7S/c1-14-9-26-21(31-14)13-30-16-8-17(30)12-29(11-16)20-7-6-15(10-25-20)23-27-19-5-3-2-4-18(19)22(24)28-23/h2-7,9-10,16-17H,8,11-13H2,1H3,(H2,24,27,28) |
| InChIKey | XEVBIEQAVNOJHE-UHFFFAOYSA-N |
| XLogP | 3.50 |
| TPSA | 84.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.55 |
| LogP ≤ 5 | 3.50 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155725193 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.